Učitavanje...

Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse

Leukemia relapse remains the major cause of allogeneic hematopoietic stem cell transplantation (HCT) failure, and the prognosis for patients with post-HCT relapse is poor. There is compelling evidence that potent selective antileukemic effects can be delivered by donor T cells specific for particula...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood
Glavni autori: Dossa, Robson G., Cunningham, Tanya, Sommermeyer, Daniel, Medina-Rodriguez, Indira, Biernacki, Melinda A., Foster, Kimberly, Bleakley, Marie
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5755045/
https://ncbi.nlm.nih.gov/pubmed/29051183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-07-791608
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!